# Angélica Nogueira Rodrigues

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/angelica-nogueira-rodrigues/

## Facts

| Field | Value |
| --- | --- |
| Citations | 165 |
| Field | Women's cancer prevention and management |
| h-index | 7 |
| i10-index | 5 |
| Last Known Institution | Universidade Federal de Minas Gerais |
| OpenAlex ID | https://openalex.org/A5000320880 |
| Works | 42 |

## Researcher papers

- [Mutation screening of TP53, CHEK2 and BRCA genes in patients at high risk for hereditary breast and ovarian cancer (HBOC) in Brazil](https://scholariq.org/papers/mutation-screening-of-tp53-chek2-and-brca-genes-in-patients-at-high-risk-for/)
- [ENGOT-cx11/KEYNOTE-A18: A phase III, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer.](https://scholariq.org/papers/engot-cx11-keynote-a18-a-phase-iii-randomized-double-blind-study-of/)
- [Screening of the BRCA1 gene in Brazilian patients with breast and/or ovarian cancer via high-resolution melting reaction analysis](https://scholariq.org/papers/screening-of-the-brca1-gene-in-brazilian-patients-with-breast-and-or-ovarian/)
- [Characteristics of patients diagnosed with cervical cancer in Brazil: preliminary results of the prospective cohort EVITA study (EVA001/LACOG 0215)](https://scholariq.org/papers/characteristics-of-patients-diagnosed-with-cervical-cancer-in-brazil-preliminary/)
- [Barriers to Primary Debulking Surgery for Advanced Ovarian Cancer in Latin America](https://scholariq.org/papers/barriers-to-primary-debulking-surgery-for-advanced-ovarian-cancer-in-latin/)
- [Immunohistochemical WWOX Expression and Association with Angiogenesis, p53 Expression, Cell Proliferation and Clinicopathological Parameters in Cervical Cancer](https://scholariq.org/papers/immunohistochemical-wwox-expression-and-association-with-angiogenesis-p53/)
- [Factors associated with HPV vaccine hesitancy: A nationally representative cross-sectional study](https://scholariq.org/papers/factors-associated-with-hpv-vaccine-hesitancy-a-nationally-representative-cross/)
- [Exploring global barriers to optimal ovarian cancer care: thematic analysis](https://scholariq.org/papers/exploring-global-barriers-to-optimal-ovarian-cancer-care-thematic-analysis/)
- [Preliminary results from CECILIA, an open-label global safety study of bevacizumab (BEV), carboplatin (C) and paclitaxel (P) therapy for metastatic, recurrent or persistent cervical cancer (CC).](https://scholariq.org/papers/preliminary-results-from-cecilia-an-open-label-global-safety-study-of/)
- [Recommendations for the treatment of vulvar cancer in settings with limited resources: Report from the International Gynecological Cancer Society consensus meeting](https://scholariq.org/papers/recommendations-for-the-treatment-of-vulvar-cancer-in-settings-with-limited/)

## Researcher topics

- [Women's cancer prevention and management](https://scholariq.org/topics/women-s-cancer-prevention-and-management/)
- [Advances in Oncology and Radiotherapy](https://scholariq.org/topics/advances-in-oncology-and-radiotherapy/)
- [Cervical Cancer and HPV Research](https://scholariq.org/topics/cervical-cancer-and-hpv-research/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Global Cancer Incidence and Screening](https://scholariq.org/topics/global-cancer-incidence-and-screening/)

## Researcher university

- [Universidade Federal de Minas Gerais](https://scholariq.org/institutions/universidade-federal-de-minas-gerais/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.